Drug & intervention

asenapine

RxCUI 784649

Clinical trials21
Recruiting0
Related conditions10
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

21 shown
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)NCT02600741 · 2015-07-24
COMPLETED
Investigator Initiated Study - Asenapine Early PsychosisNCT01968161 · 2013-10-01
UNKNOWN
Bio-equivalence Study Between SAPHRIS and AsenapineNCT01948024 · 2013-07-01
COMPLETED
A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688)NCT01617187 · 2012-12-04
COMPLETED
Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)NCT01617200 · 2012-12-01
COMPLETED
Treating Acutely Agitated Patients With Asenapine Sublingual TabletsNCT01400113 · 2012-04-01
COMPLETED
Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238)NCT01244828 · 2011-04-05
COMPLETED
Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)NCT01190267 · 2010-09-28
COMPLETED
Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125)NCT01142596 · 2010-05-25
COMPLETED
Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)NCT00281320 · 2006-02-01
COMPLETED
6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777)NCT00265343 · 2005-12-01
COMPLETED
Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785)NCT00156065 · 2005-09-01
COMPLETED
Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)NCT00156104 · 2005-07-01
COMPLETED
6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772)NCT00174265 · 2005-07-01
COMPLETED
Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)NCT00156117 · 2005-05-12
COMPLETED
Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)NCT00212836 · 2005-04-21
COMPLETED
Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784)NCT00156091 · 2005-04-01
COMPLETED
Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)NCT00151424 · 2005-02-15
COMPLETED
Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771)NCT00145496 · 2004-12-01
COMPLETED
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846)NCT00212771 · 2004-09-01
COMPLETED
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)NCT00212784 · 2003-09-04
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.